Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Malformations | 17 | 2022 | 470 | 2.500 |
Why?
|
Lymphatic Abnormalities | 7 | 2019 | 134 | 2.290 |
Why?
|
Hemangioendothelioma | 6 | 2018 | 112 | 1.540 |
Why?
|
Sarcoma, Kaposi | 5 | 2016 | 376 | 1.250 |
Why?
|
Thrombosis | 13 | 2018 | 2955 | 1.240 |
Why?
|
Sirolimus | 7 | 2021 | 1541 | 0.940 |
Why?
|
Thrombophilia | 5 | 2013 | 308 | 0.820 |
Why?
|
Esophageal Atresia | 2 | 2016 | 225 | 0.780 |
Why?
|
Angiomatosis | 2 | 2017 | 46 | 0.680 |
Why?
|
Osteolysis, Essential | 2 | 2018 | 30 | 0.620 |
Why?
|
Thromboembolism | 2 | 2014 | 1001 | 0.560 |
Why?
|
Neck | 2 | 2021 | 735 | 0.540 |
Why?
|
Colitis | 2 | 2014 | 1239 | 0.490 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2015 | 25 | 0.490 |
Why?
|
Perinatal Care | 1 | 2017 | 243 | 0.470 |
Why?
|
Skin Diseases | 3 | 2021 | 1083 | 0.470 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2015 | 103 | 0.460 |
Why?
|
Heparin | 3 | 2018 | 1632 | 0.460 |
Why?
|
Venous Thromboembolism | 3 | 2020 | 1883 | 0.450 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2014 | 2430 | 0.450 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 245 | 0.410 |
Why?
|
Anticoagulants | 5 | 2018 | 4856 | 0.410 |
Why?
|
Immunosuppressive Agents | 4 | 2021 | 4213 | 0.410 |
Why?
|
Vincristine | 1 | 2015 | 1037 | 0.410 |
Why?
|
Infant | 28 | 2023 | 36426 | 0.410 |
Why?
|
Pulmonary Embolism | 3 | 2018 | 2596 | 0.400 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2014 | 206 | 0.390 |
Why?
|
Infant, Newborn, Diseases | 1 | 2017 | 587 | 0.380 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2015 | 615 | 0.370 |
Why?
|
Face | 1 | 2017 | 1029 | 0.370 |
Why?
|
Steroids | 1 | 2015 | 934 | 0.340 |
Why?
|
Thrombocytopenia | 2 | 2014 | 1172 | 0.330 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2011 | 187 | 0.330 |
Why?
|
Blood Coagulation | 5 | 2018 | 1171 | 0.320 |
Why?
|
Catheterization, Central Venous | 1 | 2014 | 538 | 0.310 |
Why?
|
Stroke | 5 | 2023 | 9739 | 0.300 |
Why?
|
Child, Preschool | 24 | 2021 | 42510 | 0.290 |
Why?
|
Child | 30 | 2023 | 80568 | 0.290 |
Why?
|
Cranial Sinuses | 2 | 2017 | 68 | 0.280 |
Why?
|
Fibrinolytic Agents | 2 | 2014 | 2076 | 0.280 |
Why?
|
Musculoskeletal Abnormalities | 2 | 2018 | 101 | 0.270 |
Why?
|
Hemorrhage | 3 | 2018 | 3466 | 0.270 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 2 | 2018 | 69 | 0.260 |
Why?
|
Nevus | 2 | 2018 | 204 | 0.250 |
Why?
|
Lipoma | 2 | 2018 | 294 | 0.250 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 931 | 0.240 |
Why?
|
Lipoproteins | 1 | 2009 | 870 | 0.240 |
Why?
|
Infant, Newborn | 15 | 2021 | 26380 | 0.230 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2017 | 360 | 0.230 |
Why?
|
Patient Care Team | 1 | 2015 | 2515 | 0.220 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7423 | 0.220 |
Why?
|
Adolescent | 24 | 2021 | 88811 | 0.220 |
Why?
|
Lymph Nodes | 1 | 2013 | 3447 | 0.200 |
Why?
|
Cardiac Surgical Procedures | 5 | 2018 | 3682 | 0.200 |
Why?
|
Retrospective Studies | 21 | 2023 | 81537 | 0.190 |
Why?
|
Gene Deletion | 1 | 2009 | 2667 | 0.190 |
Why?
|
Male | 44 | 2021 | 363815 | 0.190 |
Why?
|
Veins | 2 | 2018 | 768 | 0.190 |
Why?
|
Humans | 66 | 2023 | 765926 | 0.180 |
Why?
|
Quality Improvement | 1 | 2016 | 3847 | 0.180 |
Why?
|
Hematology | 2 | 2017 | 243 | 0.180 |
Why?
|
Partial Thromboplastin Time | 2 | 2018 | 203 | 0.180 |
Why?
|
Transferrin | 2 | 2005 | 283 | 0.180 |
Why?
|
Female | 42 | 2023 | 396141 | 0.180 |
Why?
|
Factor Xa | 2 | 2018 | 165 | 0.170 |
Why?
|
Risk Factors | 15 | 2020 | 74850 | 0.170 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5333 | 0.170 |
Why?
|
Heart Defects, Congenital | 4 | 2018 | 4712 | 0.170 |
Why?
|
Venous Thrombosis | 1 | 2009 | 1319 | 0.170 |
Why?
|
Thalidomide | 2 | 2016 | 886 | 0.170 |
Why?
|
Boston | 7 | 2022 | 9334 | 0.160 |
Why?
|
Sclerotherapy | 3 | 2019 | 184 | 0.160 |
Why?
|
Antibodies, Anticardiolipin | 3 | 2013 | 62 | 0.160 |
Why?
|
Ultrasonography, Prenatal | 2 | 2017 | 1772 | 0.160 |
Why?
|
Angiofibroma | 1 | 2019 | 55 | 0.160 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11196 | 0.150 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2019 | 52 | 0.150 |
Why?
|
Protein-Losing Enteropathies | 1 | 2018 | 45 | 0.150 |
Why?
|
Young Adult | 16 | 2021 | 59857 | 0.150 |
Why?
|
Postoperative Complications | 4 | 2017 | 15802 | 0.150 |
Why?
|
Thoracic Duct | 1 | 2018 | 71 | 0.150 |
Why?
|
Chylothorax | 1 | 2018 | 83 | 0.150 |
Why?
|
Mucous Membrane | 1 | 2021 | 658 | 0.140 |
Why?
|
Soft Tissue Neoplasms | 2 | 2019 | 1163 | 0.140 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 3270 | 0.140 |
Why?
|
Cation Transport Proteins | 4 | 2001 | 325 | 0.140 |
Why?
|
Lower Extremity | 3 | 2020 | 1219 | 0.140 |
Why?
|
Varicose Veins | 1 | 2018 | 158 | 0.130 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2019 | 287 | 0.130 |
Why?
|
Angiopoietins | 1 | 2016 | 86 | 0.130 |
Why?
|
Upper Extremity | 2 | 2019 | 681 | 0.130 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2017 | 141 | 0.130 |
Why?
|
Endothelial Cells | 2 | 2022 | 3586 | 0.120 |
Why?
|
Muscular Diseases | 1 | 2020 | 551 | 0.120 |
Why?
|
Placenta Diseases | 1 | 2018 | 199 | 0.120 |
Why?
|
Platelet Function Tests | 1 | 2017 | 276 | 0.120 |
Why?
|
Cerebral Palsy | 1 | 2020 | 481 | 0.120 |
Why?
|
Lymphatic System | 1 | 2016 | 250 | 0.120 |
Why?
|
Drug Monitoring | 2 | 2018 | 960 | 0.120 |
Why?
|
Wnt Proteins | 1 | 2019 | 722 | 0.120 |
Why?
|
Health Resources | 1 | 2021 | 950 | 0.120 |
Why?
|
Incidence | 5 | 2020 | 21513 | 0.120 |
Why?
|
Head | 1 | 2021 | 926 | 0.120 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 992 | 0.120 |
Why?
|
Propranolol | 1 | 2016 | 494 | 0.120 |
Why?
|
Algorithms | 1 | 2015 | 14064 | 0.110 |
Why?
|
Wilms Tumor | 1 | 2017 | 378 | 0.110 |
Why?
|
Factor VIII | 2 | 2013 | 347 | 0.110 |
Why?
|
Arteriovenous Fistula | 1 | 2017 | 318 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 418 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.110 |
Why?
|
Diagnostic Imaging | 2 | 2019 | 3530 | 0.110 |
Why?
|
von Willebrand Factor | 1 | 2017 | 681 | 0.110 |
Why?
|
Thoracic Vertebrae | 1 | 2018 | 614 | 0.110 |
Why?
|
Diphosphonates | 1 | 2018 | 625 | 0.110 |
Why?
|
Hemangioma | 1 | 2018 | 724 | 0.110 |
Why?
|
Muscle, Skeletal | 3 | 2020 | 4959 | 0.110 |
Why?
|
Tracheostomy | 1 | 2017 | 430 | 0.110 |
Why?
|
Hemoglobinuria | 1 | 2012 | 12 | 0.100 |
Why?
|
Liver Neoplasms | 2 | 2019 | 4349 | 0.100 |
Why?
|
Oliguria | 1 | 2012 | 20 | 0.100 |
Why?
|
Interferons | 1 | 2016 | 714 | 0.100 |
Why?
|
Blood Coagulation Tests | 1 | 2013 | 267 | 0.100 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8522 | 0.100 |
Why?
|
Lung | 3 | 2022 | 10046 | 0.100 |
Why?
|
Spinal Cord | 1 | 2020 | 1786 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12973 | 0.100 |
Why?
|
Ventricular Function | 1 | 2013 | 403 | 0.090 |
Why?
|
Progesterone Congeners | 1 | 2011 | 42 | 0.090 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2012 | 115 | 0.090 |
Why?
|
Scoliosis | 1 | 2018 | 793 | 0.090 |
Why?
|
Catheters, Indwelling | 1 | 2013 | 436 | 0.090 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 559 | 0.090 |
Why?
|
Peripheral Vascular Diseases | 1 | 2014 | 489 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2016 | 1238 | 0.090 |
Why?
|
Prognosis | 5 | 2019 | 29890 | 0.090 |
Why?
|
Adenosine Triphosphatases | 1 | 1994 | 839 | 0.090 |
Why?
|
Metals | 1 | 1994 | 709 | 0.090 |
Why?
|
Orthopedic Procedures | 1 | 2020 | 1279 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1276 | 0.080 |
Why?
|
Consensus | 1 | 2019 | 3202 | 0.080 |
Why?
|
Cell-Derived Microparticles | 1 | 2011 | 160 | 0.080 |
Why?
|
Alleles | 1 | 2000 | 6891 | 0.080 |
Why?
|
Treatment Outcome | 9 | 2020 | 65194 | 0.080 |
Why?
|
Thromboplastin | 1 | 2011 | 289 | 0.080 |
Why?
|
Medical Oncology | 2 | 2018 | 2339 | 0.080 |
Why?
|
Adult | 15 | 2021 | 223088 | 0.080 |
Why?
|
Placenta | 1 | 2018 | 1726 | 0.080 |
Why?
|
Recurrence | 2 | 2020 | 8492 | 0.080 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 1850 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3498 | 0.070 |
Why?
|
Catheterization | 1 | 2013 | 1426 | 0.070 |
Why?
|
Iron-Binding Proteins | 2 | 1998 | 83 | 0.070 |
Why?
|
Mutation | 5 | 2017 | 30192 | 0.070 |
Why?
|
Abnormalities, Multiple | 1 | 2015 | 1424 | 0.070 |
Why?
|
Body Weight | 2 | 2017 | 4627 | 0.070 |
Why?
|
Membrane Proteins | 5 | 2005 | 7847 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2559 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2530 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 789 | 0.070 |
Why?
|
Awareness | 1 | 2011 | 653 | 0.070 |
Why?
|
Angiogenesis Inhibitors | 1 | 2016 | 2046 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6306 | 0.070 |
Why?
|
Genetic Testing | 1 | 2019 | 3594 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3135 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3801 | 0.060 |
Why?
|
Amino Acid Substitution | 2 | 2001 | 1740 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2877 | 0.060 |
Why?
|
Colon | 1 | 2013 | 1796 | 0.060 |
Why?
|
Pain | 1 | 2020 | 5077 | 0.060 |
Why?
|
Sciatic Nerve | 2 | 1999 | 623 | 0.060 |
Why?
|
Cohort Studies | 3 | 2017 | 41680 | 0.060 |
Why?
|
Pregnancy | 4 | 2023 | 30230 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15401 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 5987 | 0.060 |
Why?
|
Bacteria | 1 | 1994 | 2210 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14643 | 0.050 |
Why?
|
Disease Progression | 2 | 2017 | 13614 | 0.050 |
Why?
|
Age Factors | 3 | 2018 | 18382 | 0.050 |
Why?
|
Anemia | 2 | 2005 | 1514 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2018 | 1435 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 1999 | 1119 | 0.050 |
Why?
|
Carrier Proteins | 3 | 2001 | 4909 | 0.050 |
Why?
|
Brain | 2 | 2020 | 27179 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 904 | 0.050 |
Why?
|
Mononuclear Phagocyte System | 1 | 2001 | 55 | 0.050 |
Why?
|
Running | 1 | 2006 | 488 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8037 | 0.050 |
Why?
|
GTP-Binding Proteins | 1 | 2005 | 944 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7193 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39228 | 0.050 |
Why?
|
Glutathione Peroxidase | 2 | 1999 | 257 | 0.040 |
Why?
|
Administration, Oral | 2 | 2021 | 4016 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4278 | 0.040 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2001 | 313 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2331 | 0.040 |
Why?
|
Risk Assessment | 4 | 2018 | 24275 | 0.040 |
Why?
|
Hemochromatosis | 1 | 2001 | 175 | 0.040 |
Why?
|
Vascular Surgical Procedures | 2 | 2018 | 1506 | 0.040 |
Why?
|
Hemoglobins | 1 | 2005 | 1531 | 0.040 |
Why?
|
Survival Rate | 1 | 2013 | 12822 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2012 | 3615 | 0.040 |
Why?
|
Iron | 4 | 2005 | 1811 | 0.040 |
Why?
|
United States | 3 | 2018 | 72909 | 0.040 |
Why?
|
Time Factors | 6 | 2018 | 40097 | 0.040 |
Why?
|
Magnetic Resonance Angiography | 2 | 2017 | 1429 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2001 | 855 | 0.040 |
Why?
|
Quality of Life | 2 | 2017 | 13463 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36547 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 298 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2001 | 2743 | 0.040 |
Why?
|
Lymphography | 1 | 2018 | 189 | 0.040 |
Why?
|
Pediatrics | 2 | 2018 | 3609 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15828 | 0.040 |
Why?
|
Prospective Studies | 5 | 2023 | 54807 | 0.040 |
Why?
|
Protein Kinase C | 2 | 1999 | 1202 | 0.030 |
Why?
|
Phlebography | 1 | 2018 | 326 | 0.030 |
Why?
|
Cloning, Molecular | 3 | 2001 | 4163 | 0.030 |
Why?
|
Chorioamnionitis | 1 | 2018 | 154 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2018 | 527 | 0.030 |
Why?
|
Smoking | 1 | 2013 | 9082 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2018 | 462 | 0.030 |
Why?
|
Perioperative Period | 1 | 2017 | 252 | 0.030 |
Why?
|
DNA, Complementary | 2 | 2001 | 1984 | 0.030 |
Why?
|
Perfusion Imaging | 1 | 2017 | 193 | 0.030 |
Why?
|
Menkes Kinky Hair Syndrome | 1 | 1994 | 18 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 1677 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6766 | 0.030 |
Why?
|
Glycine | 1 | 1998 | 671 | 0.030 |
Why?
|
Chemoprevention | 1 | 2017 | 327 | 0.030 |
Why?
|
Arginine | 1 | 1998 | 931 | 0.030 |
Why?
|
Mice, Mutant Strains | 3 | 2005 | 1748 | 0.030 |
Why?
|
Hepatolenticular Degeneration | 1 | 1994 | 73 | 0.030 |
Why?
|
Middle Aged | 7 | 2021 | 223016 | 0.030 |
Why?
|
Bronchoalveolar Lavage | 1 | 2014 | 131 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2018 | 356 | 0.030 |
Why?
|
Plasminogen Inactivators | 1 | 2013 | 37 | 0.030 |
Why?
|
Histidine | 1 | 1994 | 301 | 0.030 |
Why?
|
Platelet Aggregation | 1 | 2017 | 769 | 0.030 |
Why?
|
Diabetic Neuropathies | 1 | 1998 | 407 | 0.030 |
Why?
|
DNA Probes | 1 | 1994 | 541 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2005 | 17596 | 0.030 |
Why?
|
Protein S | 1 | 2012 | 29 | 0.030 |
Why?
|
beta 2-Glycoprotein I | 1 | 2012 | 27 | 0.030 |
Why?
|
Spine | 1 | 2020 | 1132 | 0.030 |
Why?
|
Sodium Tetradecyl Sulfate | 1 | 2012 | 14 | 0.030 |
Why?
|
Antithrombin III | 1 | 2012 | 128 | 0.030 |
Why?
|
Protein C | 1 | 2012 | 134 | 0.030 |
Why?
|
Sclerosing Solutions | 1 | 2012 | 80 | 0.020 |
Why?
|
Animals | 10 | 2011 | 168735 | 0.020 |
Why?
|
Automation, Laboratory | 1 | 2012 | 102 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2001 | 2589 | 0.020 |
Why?
|
Receptors, Transferrin | 2 | 2005 | 300 | 0.020 |
Why?
|
Gene Library | 1 | 1994 | 1066 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2017 | 871 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 18074 | 0.020 |
Why?
|
Cell Membrane | 1 | 2001 | 3635 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 2013 | 372 | 0.020 |
Why?
|
Thrombin | 1 | 2013 | 601 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2001 | 13398 | 0.020 |
Why?
|
Biomedical Research | 1 | 2006 | 3458 | 0.020 |
Why?
|
Bone and Bones | 1 | 2001 | 2555 | 0.020 |
Why?
|
Species Specificity | 1 | 1994 | 2406 | 0.020 |
Why?
|
Cough | 1 | 2014 | 598 | 0.020 |
Why?
|
Calibration | 1 | 2012 | 812 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4851 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3542 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22228 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4308 | 0.020 |
Why?
|
Perioperative Care | 1 | 2017 | 1042 | 0.020 |
Why?
|
Arteriovenous Malformations | 1 | 2012 | 397 | 0.020 |
Why?
|
Developing Countries | 1 | 2021 | 2913 | 0.020 |
Why?
|
Streptococcus pneumoniae | 1 | 2014 | 761 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2018 | 1307 | 0.020 |
Why?
|
Mice | 8 | 2005 | 81782 | 0.020 |
Why?
|
Mitochondria | 1 | 2001 | 3669 | 0.020 |
Why?
|
Naphthalenes | 2 | 1999 | 197 | 0.020 |
Why?
|
Blood Glucose | 2 | 1999 | 6422 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2674 | 0.020 |
Why?
|
Fever | 1 | 2014 | 1607 | 0.020 |
Why?
|
Particle Size | 1 | 2011 | 1630 | 0.020 |
Why?
|
Oxidative Stress | 1 | 1998 | 3140 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 1117 | 0.020 |
Why?
|
Ethanol | 1 | 2012 | 1325 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2603 | 0.020 |
Why?
|
Internship and Residency | 1 | 2006 | 5945 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3612 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6058 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 2769 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10727 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2005 | 556 | 0.010 |
Why?
|
Endovascular Procedures | 1 | 2018 | 2219 | 0.010 |
Why?
|
rab GTP-Binding Proteins | 1 | 2005 | 246 | 0.010 |
Why?
|
Base Sequence | 1 | 1994 | 12405 | 0.010 |
Why?
|
Biological Transport | 2 | 1998 | 2081 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12059 | 0.010 |
Why?
|
Retroviridae | 1 | 2005 | 845 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 2005 | 662 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6941 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 521 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5449 | 0.010 |
Why?
|
Escherichia coli | 1 | 1994 | 4210 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3661 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8346 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2014 | 3314 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9656 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2005 | 1494 | 0.010 |
Why?
|
Lod Score | 1 | 2001 | 599 | 0.010 |
Why?
|
Physical Chromosome Mapping | 1 | 2001 | 183 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4555 | 0.010 |
Why?
|
Codon | 1 | 2001 | 599 | 0.010 |
Why?
|
Italy | 1 | 2001 | 851 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2001 | 1546 | 0.010 |
Why?
|
Iron Overload | 1 | 2001 | 245 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 2001 | 392 | 0.010 |
Why?
|
Mice, Inbred C57BL | 3 | 2005 | 22327 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2001 | 735 | 0.010 |
Why?
|
Enzyme Inhibitors | 2 | 1999 | 3716 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2001 | 820 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2729 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2001 | 2270 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1997 | 624 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 915 | 0.010 |
Why?
|
HLA Antigens | 1 | 2001 | 1338 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15878 | 0.010 |
Why?
|
Cytosol | 1 | 1999 | 885 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1998 | 1210 | 0.010 |
Why?
|
Aged | 2 | 2019 | 171163 | 0.010 |
Why?
|
Exons | 1 | 2001 | 2393 | 0.010 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 479 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 1997 | 784 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2001 | 1362 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20133 | 0.010 |
Why?
|
Pedigree | 1 | 2001 | 4535 | 0.010 |
Why?
|
Blotting, Western | 1 | 2001 | 5019 | 0.010 |
Why?
|
Phenotype | 2 | 2001 | 16714 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 4111 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2001 | 6209 | 0.010 |
Why?
|
Haplotypes | 1 | 1997 | 2726 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20690 | 0.010 |
Why?
|
Models, Genetic | 1 | 2001 | 3447 | 0.010 |
Why?
|
Heterozygote | 1 | 1997 | 2796 | 0.010 |
Why?
|
Homeostasis | 1 | 2001 | 3338 | 0.010 |
Why?
|
Cell Line | 1 | 2001 | 15540 | 0.000 |
Why?
|
Kidney | 1 | 1998 | 7073 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1998 | 18962 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1997 | 18292 | 0.000 |
Why?
|